This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Jourenkova-Mironova, N. Articles by Hirvonen, A. Search for Related Content PubMed PubMed Citation Articles by Jourenkova-Mironova, N. Articles by Hirvonen, A.

High-Activity Microsomal Epoxide Hydrolase Genotypes and the Risk of Oral, Pharynx, and Larynx Cancers¹

Unit of Cancer Epidemiology (Institut National de la Santé et de la Recherche Médicale U521), Institut Gustave-Roussy, 94805 Villejuif, France [N. J-M., S. B.]; Department of Industrial Hygiene and Toxicology, Finnish Institute of Occupational Health, 00250 Helsinki, Finland [K. M., A. H.]; Geneva Cancer Registry, 1205 Geneva, Switzerland [C. B.]; Division of Clinical Pharmacology, University Hospital of Geneva, 1211 Geneva, Switzerland [P. D.]

Human microsomal epoxide hydrolase (mEH), encoded by the EPHX1 gene, is involved in the metabolism of tobacco carcinogens. We investigated the effect of exon 3 and 4 polymorphisms of the EPHX1 gene in 121 patients with cancers of the oral cavity/pharynx, 129 patients with cancer of the larynx, and 172 non-cancer controls, all Caucasian regular smokers. The potential modifying role of previously analyzed GSTM1, GSTM3, and GSTP1 genotypes was also examined. Compared with the putative low-activity genotypes, odds ratios (ORs) associated with predicted intermediate and high mEH activity genotypes were significantly increased for oropharyngeal cancers [OR = 1.8; 95% confidence interval (CI) = 1.0–3.3; and OR = 2.1; 95% CI = 1.0–4.5, respectively; P_trend = 0.03] and laryngeal cancers (OR = 1.7; 95% CI = 1.0–3.1; and OR = 2.4; 95% CI = 1.1–5.1, respectively; P_trend = 0.02). Moreover, a positive interaction was found between mEH activity and GSTM3 genotype for laryngeal cancer. The combined EPHX1 high activity-associated genotype and GSTM3 (AB or BB) genotype conferred a 13.1-fold risk (95% CI = 3.5–48.4) compared with the concurrent presence of the EPHX1 low activity-associated genotype and the GSTM3 AA genotype. Thus, EPHX1 polymorphisms may be one of the factors of importance in susceptibility to smoking-related cancers of the upper aerodigestive tract.

This article has been cited by other articles:

				M. LACKO, M. B. O. OPHUIS, W. H.M. PETERS, and J. J. MANNI Genetic Polymorphisms of Smoking-related Carcinogen Detoxifying Enzymes and Head and Neck Cancer Susceptibility Anticancer Res, February 1, 2009; 29(2): 753 - 761. [Abstract] [Full Text] [PDF]

				S. Michiels, P. Danoy, P. Dessen, A. Bera, T. Boulet, C. Bouchardy, M. Lathrop, A. Sarasin, and S. Benhamou Polymorphism discovery in 62 DNA repair genes and haplotype associations with risks for lung and head and neck cancers Carcinogenesis, August 1, 2007; 28(8): 1731 - 1739. [Abstract] [Full Text] [PDF]

				P. N. Mitrou, M. A. Watson, A. S. Loktionov, C. Cardwell, M. J. Gunter, W. S. Atkin, C. P. Macklin, T. Cecil, D.T. Bishop, J. Primrose, et al. Role of NQO1C609T and EPHX1 gene polymorphisms in the association of smoking and alcohol with sporadic distal colorectal adenomas: results from the UKFSS Study Carcinogenesis, April 1, 2007; 28(4): 875 - 882. [Abstract] [Full Text] [PDF]

				A. Agudo, N. Sala, G. Pera, G. Capella, A. Berenguer, N. Garcia, D. Palli, H. Boeing, G. Del Giudice, C. Saieva, et al. Polymorphisms in Metabolic Genes Related to Tobacco Smoke and the Risk of Gastric Cancer in the European Prospective Investigation into Cancer and Nutrition Cancer Epidemiol. Biomarkers Prev., December 1, 2006; 15(12): 2427 - 2434. [Abstract] [Full Text] [PDF]

				K. Robien, K. Curtin, C. M. Ulrich, J. Bigler, W. Samowitz, B. Caan, J. D. Potter, and M. L. Slattery Microsomal Epoxide Hydrolase Polymorphisms Are Not Associated with Colon Cancer Risk Cancer Epidemiol. Biomarkers Prev., May 1, 2005; 14(5): 1350 - 1352. [Full Text] [PDF]

				W.-Y. Huang, N. Chatterjee, S. Chanock, M. Dean, M. Yeager, R. E. Schoen, L.-F. Hou, S. I. Berndt, S. Yadavalli, C. C. Johnson, et al. Microsomal Epoxide Hydrolase Polymorphisms and Risk for Advanced Colorectal Adenoma Cancer Epidemiol. Biomarkers Prev., January 1, 2005; 14(1): 152 - 157. [Abstract] [Full Text] [PDF]

				G. J. Tranah, E. Giovannucci, J. Ma, C. Fuchs, S. E. Hankinson, and D. J. Hunter Epoxide hydrolase polymorphisms, cigarette smoking and risk of colorectal adenoma in the Nurses' Health Study and the Health Professionals Follow-up Study Carcinogenesis, July 1, 2004; 25(7): 1211 - 1218. [Abstract] [Full Text] [PDF]

				D J de Jong, E M J van der Logt, A van Schaik, H M J Roelofs, W H M Peters, and T H J Naber Genetic polymorphisms in biotransformation enzymes in Crohn's disease: association with microsomal epoxide hydrolase Gut, April 1, 2003; 52(4): 547 - 551. [Abstract] [Full Text] [PDF]

				K. Leffondre, M. Abrahamowicz, J. Siemiatycki, and B. Rachet Modeling Smoking History: A Comparison of Different Approaches Am. J. Epidemiol., November 1, 2002; 156(9): 813 - 823. [Abstract] [Full Text] [PDF]

				A. Loktionov, M. A. Watson, M. Gunter, W. S.L. Stebbings, C. T.M. Speakman, and S. A. Bingham Glutathione-S-transferase gene polymorphisms in colorectal cancer patients: interaction between GSTM1 and GSTM3 allele variants as a risk-modulating factor Carcinogenesis, July 1, 2001; 22(7): 1053 - 1060. [Abstract] [Full Text] [PDF]

				J. Sarmanova, K. Benesova, I. Gut, V. Nedelcheva-Kristensen, L. Tynkova, and P. Soucek Genetic polymorphisms of biotransformation enzymes in patients with Hodgkin's and non-Hodgkin's lymphomas Hum. Mol. Genet., June 1, 2001; 10(12): 1265 - 1273. [Abstract] [Full Text] [PDF]

				X. Wu, K. Gwyn, C. I. Amos, N. Makan, W. K. Hong, and M. R. Spitz The association of microsomal epoxide hydrolase polymorphisms and lung cancer risk in African-Americans and Mexican-Americans Carcinogenesis, June 1, 2001; 22(6): 923 - 928. [Abstract] [Full Text] [PDF]

				W. Zhou, S. W. Thurston, G. Liu, L. L. Xu, D. P. Miller, J. C. Wain, T. J. Lynch, L. Su, and D. C. Christiani The Interaction between Microsomal Epoxide Hydrolase Polymorphisms and Cumulative Cigarette Smoking in Different Histological Subtypes of Lung Cancer Cancer Epidemiol. Biomarkers Prev., May 1, 2001; 10(5): 461 - 466. [Abstract] [Full Text]

				D. Schwarz, P. Kisselev, I. Cascorbi, W.-H. Schunck, and I. Roots Differential metabolism of benzo[a]pyrene and benzo[a]pyrene-7,8-dihydrodiol by human CYP1A1 variants Carcinogenesis, March 1, 2001; 22(3): 453 - 459. [Abstract] [Full Text] [PDF]

				V. Cortessis, K. Siegmund, Q. Chen, N. Zhou, A. Diep, H. Frankl, E. Lee, Q.-s. Zhu, R. Haile, and D. Levy A Case-Control Study of Microsomal Epoxide Hydrolase, Smoking, Meat Consumption, Glutathione S-Transferase M3, and Risk of Colorectal Adenomas Cancer Res., March 1, 2001; 61(6): 2381 - 2385. [Abstract] [Full Text]